You have 9 free searches left this month | for more free features.

City

Antwerpen (1)

Berlin (1)

Botosani (1)

Brasov (1)

Codru (1)

Craiova (1)

Erlangen (1)

Munchen (1)

Neuss (1)

Condition

Alzheimer's Disease (1)

Cognition Disorders (1)

Depression (1)

Healthy (1)

Healthy Volunteers (1)

Schizophrenia (1)

Overall Status

Completed (3)

Terminated (1)

Sign in for free

Phase

phase 1 (3)

phase 2 (1)

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)

Janssen Pharmaceutica N.V., Belgium (1)

Tangent Data (1)

Collaborator

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)

Intervention

jnj-39393406 (4)

placebo (4)

Study Documents

Intervention Type

drug (4)

other (1)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (4)

jnj-39393406

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Depression Trial in Moldova, Republic of, Romania (JNJ-39393406, Placebo)

Completed

Depression

JNJ-39393406
Placebo

Codru, Moldova, Republic of
+3 more

May 20, 2020

Healthy Trial in Antwerpen (JNJ-39393406, Placebo)

Completed

Healthy

JNJ-39393406
Placebo

Antwerpen, Belgium

(unnamed)

Jan 23, 2014

Healthy Volunteers Trial (JNJ-39393406, Placebo)

Completed

Healthy Volunteers

JNJ-39393406
Placebo

(no location specified)

Jul 23, 2013

Schizophrenia, Alzheimer's Disease, Cognition Disorders Trial in Germany (JNJ-39393406, )

Terminated

Schizophrenia
+2 more

JNJ-39393406
placebo

Berlin, Germany
+3 more

Nov 7, 2012